A detailed history of First National Bank Of Omaha transactions in Eli Lilly & CO stock. As of the latest transaction made, First National Bank Of Omaha holds 11,882 shares of LLY stock, worth $9.45 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
11,882
Previous 12,986 8.5%
Holding current value
$9.45 Million
Previous $11.8 Million 10.47%
% of portfolio
0.71%
Previous 0.82%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$772.14 - $960.02 $852,442 - $1.06 Million
-1,104 Reduced 8.5%
11,882 $10.5 Million
Q2 2024

Aug 15, 2024

SELL
$724.87 - $909.04 $2.26 Million - $2.84 Million
-3,121 Reduced 19.38%
12,986 $11.8 Million
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $1.69 Million - $2.27 Million
-2,859 Reduced 15.07%
16,107 $12.5 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $3.54 Million - $4.17 Million
-6,732 Reduced 26.2%
18,966 $11.1 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $3.18 Million - $4.39 Million
-7,319 Reduced 22.17%
25,698 $13.8 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $4.15 Million - $5.55 Million
-11,832 Reduced 26.38%
33,017 $15.5 Million
Q1 2023

May 03, 2023

SELL
$310.63 - $364.82 $611,630 - $718,330
-1,969 Reduced 4.21%
44,849 $15.4 Million
Q4 2022

Feb 08, 2023

SELL
$321.55 - $374.67 $1.11 Million - $1.29 Million
-3,455 Reduced 6.87%
46,818 $17.1 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $343,323 - $391,253
-1,158 Reduced 2.25%
50,273 $16.3 Million
Q2 2022

Sep 06, 2022

SELL
$278.73 - $327.27 $369,874 - $434,287
-1,327 Reduced 2.52%
51,431 $16.7 Million
Q1 2022

May 25, 2022

BUY
$234.69 - $291.66 $867,883 - $1.08 Million
3,698 Added 7.54%
52,758 $15.1 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $560,551 - $695,646
-2,493 Reduced 4.84%
49,060 $13.6 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $902,798 - $1.11 Million
-4,074 Reduced 7.32%
51,553 $11.9 Million
Q1 2021

May 06, 2021

SELL
$164.32 - $212.72 $1.16 Million - $1.5 Million
-7,068 Reduced 11.27%
55,627 $10.4 Million
Q4 2020

Feb 18, 2021

SELL
$130.46 - $172.63 $40,833 - $54,033
-313 Reduced 0.5%
62,695 $10.6 Million
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $205,292 - $237,458
-1,404 Reduced 2.18%
63,008 $9.33 Million
Q2 2020

Aug 05, 2020

SELL
$136.42 - $164.18 $1.2 Million - $1.45 Million
-8,826 Reduced 12.05%
64,412 $10.6 Million
Q1 2020

Apr 29, 2020

SELL
$119.05 - $147.35 $155,241 - $192,144
-1,304 Reduced 1.75%
73,238 $10.2 Million
Q4 2019

Jan 17, 2020

SELL
$106.92 - $132.43 $347,703 - $430,662
-3,252 Reduced 4.18%
74,542 $9.8 Million
Q3 2019

Nov 04, 2019

SELL
$106.79 - $116.16 $266,975 - $290,400
-2,500 Reduced 3.11%
77,794 $8.7 Million
Q2 2019

Jul 10, 2019

SELL
$110.79 - $129.32 $943,155 - $1.1 Million
-8,513 Reduced 9.59%
80,294 $8.9 Million
Q1 2019

May 01, 2019

SELL
$111.31 - $131.02 $919,197 - $1.08 Million
-8,258 Reduced 8.51%
88,807 $11.5 Million
Q4 2018

Jan 23, 2019

BUY
$105.9 - $118.64 $10.3 Million - $11.5 Million
97,065 New
97,065 $11.2 Million
Q4 2018

Jan 22, 2019

SELL
$105.9 - $118.64 $10.7 Million - $12 Million
-100,758 Closed
0 $0
Q3 2018

Nov 05, 2018

SELL
$85.86 - $107.31 $50,056 - $62,561
-583 Reduced 0.58%
100,758 $10.8 Million
Q2 2018

Jul 12, 2018

BUY
$75.7 - $86.88 $62,376 - $71,589
824 Added 0.82%
101,341 $8.65 Million
Q1 2018

May 03, 2018

SELL
$74.21 - $87.6 $10,240 - $12,088
-138 Reduced 0.14%
100,517 $7.78 Million
Q4 2017

Feb 05, 2018

BUY
$81.94 - $87.89 $8.25 Million - $8.85 Million
100,655
100,655 $8.5 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First National Bank Of Omaha Portfolio

Follow First National Bank Of Omaha and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.